Stock AORT ARTIVION, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Artivion, Inc.

Equities

AORT

US2289031005

Medical Equipment, Supplies & Distribution

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
20.57 USD +1.48% Intraday chart for Artivion, Inc. +2.70% +15.04%
Mar. 01 Artivion Files Mixed Shelf MT
Feb. 22 Artivion Insider Sold Shares Worth $1,358,818, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,016 917.4 800.4 488.8 733.9 858 - -
Enterprise Value (EV) 1 1,016 917.4 1,058 761.4 733.9 858 858 858
P/E ratio 542 x -53.7 x -53.6 x -25.3 x -23.8 x -70 x 168 x 79.1 x
Yield - - - - - - - -
Capitalization / Revenue 3.68 x 3.62 x 2.68 x 1.56 x 2.07 x 2.21 x 2.01 x 1.82 x
EV / Revenue 3.68 x 3.62 x 2.68 x 1.56 x 2.07 x 2.21 x 2.01 x 1.82 x
EV / EBITDA 21.5 x 24.3 x 18.1 x 11.8 x 13.6 x 12.4 x 9.98 x 8.58 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - - 2.7 x 1.72 x - - - -
Nbr of stocks (in thousands) 37,504 38,857 39,330 40,329 41,049 41,710 - -
Reference price 2 27.09 23.61 20.35 12.12 17.88 20.57 20.57 20.57
Announcement Date 2/13/20 2/11/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 276.2 253.2 298.8 313.8 354 388 427.2 470.6
EBITDA 1 47.23 37.76 44.28 41.56 53.82 69.34 85.96 100
EBIT 1 17.04 2.441 8.117 6.201 5.742 20.27 37.91 48.2
Operating Margin 6.17% 0.96% 2.72% 1.98% 1.62% 5.22% 8.87% 10.24%
Earnings before Tax (EBT) 1 1.644 -17.17 -14.83 -14.98 -21.59 -9.258 9.275 26.2
Net income 1 1.72 -16.68 -14.83 -19.19 -30.69 -10.49 7.382 19.6
Net margin 0.62% -6.59% -4.96% -6.12% -8.67% -2.7% 1.73% 4.16%
EPS 2 0.0500 -0.4400 -0.3800 -0.4800 -0.7500 -0.2940 0.1225 0.2600
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 2/13/20 2/11/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 72.21 79.39 77.21 80.34 76.84 79.4 83.23 89.25 87.85 93.67 92.06 98.14 94.98 102.9 102.7
EBITDA 1 9.334 10.77 9.987 10.26 10.36 10.96 10.8 13.82 13.86 15.33 14.69 16.97 17.37 20.31 19.53
EBIT 1 14.69 -9.339 1.636 4.541 -4.106 4.13 -3.861 7.675 -1.244 3.172 2.838 4.6 5.112 7.742 7.08
Operating Margin 20.34% -11.76% 2.12% 5.65% -5.34% 5.2% -4.64% 8.6% -1.42% 3.39% 3.08% 4.69% 5.38% 7.53% 6.89%
Earnings before Tax (EBT) 1 7.944 -16.09 -2.429 -3.3 -12.53 3.277 -8.919 -2.657 -9.419 -0.591 -4.305 -2.832 -2.28 0.185 -0.425
Net income 1 10.58 -20.1 -3.389 -4.259 -13.71 2.169 -13.53 -3.382 -9.801 -3.975 -4.7 -3.24 -2.588 0.0625 -1.08
Net margin 14.66% -25.32% -4.39% -5.3% -17.85% 2.73% -16.26% -3.79% -11.16% -4.24% -5.11% -3.3% -2.72% 0.06% -1.05%
EPS 2 0.2600 -0.5100 -0.0800 -0.1100 -0.3400 0.0500 -0.3300 -0.0800 -0.2400 -0.1000 -0.1200 -0.0800 -0.0760 -0.0160 -0.0250
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/17/22 5/5/22 8/4/22 11/3/22 2/16/23 5/4/23 8/3/23 11/2/23 2/15/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - 258 273 - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - 5.822 x 6.558 x - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 0.61% - 1.56% 0.71% - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - 7.540 7.050 - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - - 9.02 7.43 10 12 -
Capex / Sales - - - 2.87% 2.1% 2.58% 2.81% -
Announcement Date 2/13/20 2/11/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Artivion, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
20.57 USD
Average target price
25.15 USD
Spread / Average Target
+22.27%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ARTIVION, INC. Stock Artivion, Inc.
+15.04% 858M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. AORT Stock
  4. Financials Artivion, Inc.